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Transforming Growth Factor b (TGFb) is an immunosup-
pressive cytokine that inhibits pro-inflammatory functions
of T cells, and is a major contributor to abrogating TH1
and cytotoxic T cell activity against tumors. While canoni-
cal signal transduction through effector Smads has been
well-defined as a requirement for TGFb-mediated inhibi-
tion of T cells, essential non-canonical pathways have not,
to date, been defined. This abstract describes the identifi-
cation of Platelet Endothelial Cell Adhesion Molecule-1
(PECAM-1), CD31, as a novel facilitator of non-canonical
TGFb signal transduction in T cells. Subcutaneously
injected tumor cells known to require TGFb-mediated
suppression of immunity for clearance grew more slowly
in PECAM-1-/- mice relative to wild type counterparts,
and T cells isolated from PECAM-1-/- mice demonstrated
relative insensitivity to TGFb-induced inhibition of IFNg
production and proliferation. Similarly, human T cells
lacking PECAM-1 expression demonstrated decreased
sensitivity to TGFb in a manner that could be partially
restored by re-expression of PECAM-1. Phosphorylation
of PECAM-1 on an Immunoreceptor Tyrosine-based Inhi-
bitory Motif (ITIM) and resultant binding of the inhibitory
Src homology 2 domain-containing tyrosine phosphatase-
2 (SHP-2) was observed after co-incubation of T cells with
TGFb and anti-CD3, and inducible co-localization of
PECAM-1 with the TGFb receptor complex was identified
using co-immunoprecipitation, confocal microscopy and
proximity ligation assays. These studies indicate an unex-
pected role for PECAM-1 in enhancing crucial inhibitory
functions of TGFb in T cells and suggest that targeting of
the PECAM-1/TGFb inhibitory axis represents a novel
means to overcome TGFb-dependent immunosuppression
within the tumor microenvironment.
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